Journal of the American College of Radiology
Volume 9, Issue 1 , Pages 33-41 , January 2012

Growth in the Use of PET for Six Cancer Types After Coverage by Medicare: Additive or Replacement?

  • Bruce E. Hillner, MD

      Affiliations

    • Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia
    • Corresponding Author InformationCorresponding author and reprints: Bruce E. Hillner, Virginia Commonwealth University, Department of Internal Medicine and the Massey Cancer Center, Sanger Hall, 1101 East Marshall Street, Richmond, VA 23298
    • ,
  • Anna N. Tosteson, ScD

      Affiliations

    • The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, New Hampshire
    • ,
  • Yunjie Song, PhD

      Affiliations

    • The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, New Hampshire
    • ,
  • Tor D. Tosteson, ScD

      Affiliations

    • The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, New Hampshire
    • ,
  • Tracy Onega, PhD

      Affiliations

    • The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, New Hampshire
    • ,
  • David C. Goodman, MD

      Affiliations

    • Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia
    • ,
  • Barry A. Siegel, MD

      Affiliations

    • Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, and Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri

References 

  1. National Comprehensive Cancer Network . NCCN guidelines . http://www.nccn.org/professionals/physician_gls/f_guidelines.asp Accessed December 27, 2010
  2. American College of Radiology . ACR Appropriateness Criteria® . http://www.acr.org/secondarymainmenucategories/quality_safety/app_criteria.aspx Accessed January 2, 2011
  3. Podoloff DA , Ball DW , Ben-Josef E , et al.  NCCN task force: clinical utility of PET in a variety of tumor types . J Natl Compr Canc Netw . 2009;7(suppl):S1–S26
  4. Meropol NJ , Schrag D , Smith TJ , et al.  American Society of Clinical Oncology guidance statement: the cost of cancer care . J Clin Oncol . 2009;27:3868–3874
  5. Levin DC , Rao VM , Parker L , Frangos AJ . The disproportionate effects of the Deficit Reduction Act of 2005 on radiologists' private office MRI and CT practices compared with those of other physicians . J Am Coll Radiol . 2009;6:620–625
  6. Iglehart JK . The new era of medical imaging—progress and pitfalls . N Engl J Med . 2006;354:2822–2828
  7. Parker L , Levin DC , Frangos A , Rao VM . Geographic variation in the utilization of noninvasive diagnostic imaging: national Medicare data 1998-2007 . AJR Am J Roentgenol . 2010;194:1034–1039
  8. Levin DC , Rao VM , Parker L , Frangos AJ , Sunshine JH . Recent shifts in place of service for noninvasive diagnostic imaging: have hospitals missed an opportunity? . J Am Coll Radiol . 2009;6:96–99
  9. Centers for Medicare and Medicaid Services . PM Rev AB-01-54, expanded coverage of positron emission tomography (PET) scans and related claims processing changes . http://www.cms.gov/transmittals/downloads/R136CIM.pdf December 15, 2000; Accessed January 3, 2011
  10. Welch HG , Sharp SM , Gottlieb DJ , Skinner JS , Wennberg JE . Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries . JAMA . 2011;305:1113–1118
  11. Beebe M , Dalton J , Espronceda M , Evans D . CPT 2008 professional edition . Chicago, Ill: AMA Press; 2007;
  12. Mitchell JM . Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California . Med Care . 2008;46:460–466
  13. Mitchell JM . The prevalence of physician self-referral arrangements after Stark II: evidence from advanced diagnostic imaging . Health Aff (Millwood) . 2007;26:w415–w424
  14. Smith-Bindman R , Miglioretti DL , Larson EB . Rising use of diagnostic medical imaging in a large integrated health system . Health Aff (Millwood) . 2008;27:1491–1502
  15. Medicare Payment Advisory Commission . Report to the Congress: Medicare payment policy . http://www.medpac.gov/publications/congressional_reports/Mar05_EntireReport.pdf Accessed December 30, 2010
  16. Hendee WR , Becker GJ , Borgstede JP , et al.  Addressing overutilization in medical imaging . Radiology . 2010;257:240–245
  17. Black WC , Welch HG . Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy . N Engl J Med . 1993;328:1237–1243
  18. Feinstein AR , Sosin DM , Wells CK . The Will Rogers phenomenon . N Engl J Med . 1985;312:1604–1608
  19. Rosselli Del Turco M , Palli D , Cariddi A , Ciatto S , Pacini P , Distante V . Intensive diagnostic follow-up after treatment of primary breast cancer (A randomized trial. National Research Council Project on Breast Cancer Follow-Up) . JAMA . 1994;271:1593–1597
  20. US Government Accountability Office . Medicare: trends in fees, utilization, and expenditures for imaging services before and after implementation of the Deficit Reduction Act of 2005(GAO-08-1102R) . http://www.gao.gov/new.items/d081102r.pdf Accessed January 2, 2011
  21. Rosenthal DI , Weilburg JB , Schultz T , et al.  Radiology order entry with decision support: initial clinical experience . J Am Coll Radiol . 2006;3:799–806
  22. Blackmore CC , Mecklenburg RS , Kaplan GS . Effectiveness of clinical decision support in controlling inappropriate imaging . J Am Coll Radiol . 2011;8:19–25
  23. Juweid ME , Cheson BD . Positron-emission tomography and assessment of cancer therapy . N Engl J Med . 2006;354:496–507
  24. Dinan MA , Curtis LH , Hammill BG , et al.  Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer 1999-2006 . JAMA . 2010;303:1625–1631
  25. Centers for Medicare and Medicaid Services . Pub 100-03 Medicare national coverage determinations (Transmittal 31) . http://www.cms.hhs.gov/Transmittals/downloads/R31NCD.pdf
  26. Fischer B , Lassen U , Mortensen J , et al.  Preoperative staging of lung cancer with combined PET-CT . N Engl J Med . 2009;361:32–39
  27. Herder GJM , Kramer H , Hoekstra OS , et al.  Traditional versus up-front 18F fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study . J Clin Oncol . 2006;24:1800–1806
  28. van Tinteren H , Hoekstra OS , Smit EF , et al.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial . Lancet . 2002;359:1388–1393
  29. Viney RC , Boyer MJ , King MT , et al.  Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer . J Clin Oncol . 2004;22:2357–2362
  30. Maziak DE , Darling GE , Inculet RI , et al.  Positron emission tomography in staging early lung cancer: a randomized trial . Ann Intern Med . 2009;151:221–228
  31. Chalela JA , Kidwell CS , Nentwich LM , et al.  Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison . Lancet . 2007;369:293–298
  32. van der Worp HB , van Gijn J . Clinical practice (Acute ischemic stroke) . N Engl J Med . 2007;357:572–579
  33. Morris PG , Lynch C , Feeney JN , et al.  Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer . J Clin Oncol . 2010;28:3154–3159
  34. Song JW , Oh Y-M , Shim T-S , Kim WS , Ryu J-S , Choi C-M . Efficacy comparison between 18F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer . Lung Cancer . 2009;65:333–338
  35. Takenaka D , Ohno Y , Matsumoto K , et al.  Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy . J Magn Reson Imaging . 2009;30:298–308
  36. Ozülker T , Kücükoz Uzun A , Ozüulker F , Ozpaçac T . Comparison of 18F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients . Nucl Med Commun . 2010;31:597–603
  37. Liu T , Xu J-Y , Xu W , Bai Y-R , Yan W-L , Yang H-L . Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? (A meta-analysis) . Clin Oncol . 2011;23:350–358
  38. Levin DC , Rao VM , Parker L , Frangos AJ , Sunshine JH . Bending the curve: the recent marked slowdown in growth of noninvasive diagnostic imaging . AJR Am J Roentgenol . 2011;196:W25–W29
  39. Levin DC , Rao VM . The effect of self-referral on utilization of advanced diagnostic imaging . AJR Am J Roentgenol . 2011;196:848–852
  40. Blackmore CC , Medina LS . Evidence-based radiology and the ACR Appropriateness Criteria® . J Am Coll Radiol . 2006;3:505–509
  41. Fryback DG , Thornbury JR . The efficacy of diagnostic imaging . Med Decis Making . 1991;11:88–94
  42. Metser U , You J , McSweeney S , Freeman M , Hendler A . Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen . AJR Am J Roentgenol . 2010;194:766–771
  43. Fuster D , Chiang S , Johnson G , Schuchter LM , Zhuang H , Alavi A . Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? . J Nucl Med . 2004;45:1323–1327
  44. Lonneux M , Hamoir M , Reychler H , et al.  Positron emission tomography with 18F fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study . J Clin Oncol . 2010;28:1190–1195
  45. Scott AM , Gunawardana DH , Bartholomeusz D , Ramshaw JE , Lin P . PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study . J Nucl Med . 2008;49:1593–1600
  46. Juweid ME , Stroobants S , Hoekstra OS , et al.  Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma . J Clin Oncol . 2007;25:571–578

 Primary funding source: National Institutes of Health; National Cancer Institute Grand Opportunity Award RC2CA148259.

PII: S1546-1440(11)00338-3

doi: 10.1016/j.jacr.2011.06.019

Journal of the American College of Radiology
Volume 9, Issue 1 , Pages 33-41 , January 2012

Article Tools

* Image Usage & Resolution